<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046200">
  <TermName>exatecan mesylate</TermName>
  <TermPronunciation>(EK-suh-TEE-kan MEH-zih-layt)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An anticancer drug that is a type of topoisomerase inhibitor. Also called DX-8951f.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731436" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exatecan mesylate&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731437" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;exatecán mesilato&quot;" language="es" id="_4"/>
  <SpanishTermName>exatecán mesilato</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento contra el cáncer que es un tipo de inhibidor de la topoisomerasa. También se llama DX-8951f.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2007-07-06</DateLastModified>
</GlossaryTerm>
